Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer expands Healthcare Hub programme for tech startups

London, Stockholm, Sydney and Toronto hubs open their doors

Pfizer

Pfizer has expanded its Healthcare Hub programme to provide support and resources to late-stage health tech startups.

The pharma company’s initiative was first brought to centres in New York, Berlin and Tel Aviv, and last month London, Stockholm, Sydney and Toronto hubs opened their doors.

The programme seeks startups who have developed a product or service ready for use by healthcare professionals that can show evidence of benefits to patients or clinicians.

For the London hub at stake is a share of a £56,000 grant and a year-long support programme to help with, among other things, navigating the UK’s health system. They can, however, retain complete independence from the pharma firm with no obligation to transfer intellectual property or equity to Pfizer.

Erik Nordkamp, Pfizer UK’s managing director, said: “I’m delighted that we’ll be launching the Pfizer Healthcare Hub here in the UK.

“We live in a country that is already a centre for original thinking and innovation within healthcare and our goal is to accelerate the success of the brightest start-ups in this field and help them make a difference to patients.”

Pfizer UK will this week shortlist up to 10 UK-registered companies and charities, inviting them to its Walton Oaks headquarters in Surrey.

There they will pitch their offering on 18 May to a panel of business and health leaders, among them Dr Sam Barrell from the Taunton and Somerset NHS Foundation Trust and Anna King, commercial director at the Health Innovation Network and Digital Health London. Three winners will then be announced in June.

Dr Hamish Graham, manager of Pfizer Healthcare Hub: London, said: “The Healthcare Hub will provide a platform for start-ups to harness Pfizer’s global network, enabling them to get access to our expertise, understanding and guidance.

“We hope, with our support, that they’ll be able to reach their goals and get their innovations adopted within the health service.”

Pfizer’s startup programme echoes similar work in the space by the likes of LEO Pharma and its innovation lab, Merck’s digital health accelerator, Bayer, MSD in the UK and Sandoz in mobile health.

5th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics